Yelda Jozaghi*¹, Mark E Zafereo*¹, Nancy D Perrier², Jennifer R Wang¹, Elizabeth Grubbs², Neil D Gross¹, Sarah Fisher², Erich M Sturgis¹, Ryan P Goepfert¹, Stephen Y Lai¹, Conor Best³, Naifa L Busaidy³, Maria E Cabanillas³, Ramona Dadu³, Robert F Gagel³, Mouhammed A Habra³, Mimi I Hu³, Camilo Jimenez³, Steven I Sherman³, Sonali Thosani³, Jeena Varghese³, Steven G Waguespack³, Steven Weitzman³, Anita K Ying³, Paul H Graham². *Co-first authors

¹Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.²Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.³Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

This work was not funded.

All authors participated in the manuscript drafting or review process.

This work has not been presented at any meetings or conferences.

Corresponding author: Mark E Zafereo 1515 Holcombe Boulevard Unit FCT 10.6008 Houston, Texas 77030 713-563-9683 MZafereo@mdanderson.org

Key words: Coronavirus, COVID, Endocrine, Surgery, Guideline.